跳至主要内容
临床试验/NCT01780870
NCT01780870已完成不适用

Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss

Beth Israel Deaconess Medical Center1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2012年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
5
试验地点
1
主要终点
The Primary Outcome Will be the Leptin Levels at Baseline and 8 Weeks

研究概览

简要总结

The main purpose of this study is to assess factors mediating the changes in insulin sensitivity and glucose tolerance before and after 10 lbs ± or 2% weight loss reduction as well as 2, 3, 6, 12, and 24 months after initiation of a low calorie diet.

The investigators will also study the following:

  1. The impact of diet induced weight loss on hormones/adipokine levels
  2. The impact of diet induced weight loss on leptin tolerance

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •for interventional group:
  • •Adult men and women, age 18-50
  • •English speaking
  • •Body mass index (pre weight loss) ≥30 kg/m2 but <40 kg/m2
  • •Willing to enroll in a low calorie full meal replacement weight loss program
  • •Willing and able to take part in a multi year study involving visits
  • •Inclusion Criteria for control group:
  • •Adult men and women, age 18-50
  • •English speaking
  • •Body mass index (pre weight loss) ≥30 kg/m2 but <40 kg/m2
  • •Willing and able to take part in a multi year study involving visits

排除标准

  • 未提供

研究组 & 干预措施

Control Group

No Intervention

Obese, otherwise healthy people who are not receiving any nutritional,surgical or behavioral therapy

Weight loss group

Active Comparator

Full Meal replacement Protocol

干预措施: Weight loss group (Full meal replacement products) (Dietary Supplement)

结局指标

主要结局

The Primary Outcome Will be the Leptin Levels at Baseline and 8 Weeks

时间窗: 8 weeks

The secondary outcome was deleted, since it was finally not performed in the study due to problems in enrollment

The Primary Outcome Will be Insulin Levels at Baseline and 8 Weeks

时间窗: 8 weeks

The secondary outcome was deleted, since it was finally not performed in the study due to problems in enrollment

The Primary Outcome Will be HOMA-IR at Baseline and 8 Weeks

时间窗: 8 weeks

The secondary outcome was deleted, since it was finally not performed in the study due to problems in enrollment

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Christos Mantzoros

Professor of Medicine

Beth Israel Deaconess Medical Center

研究点 (1)

Loading locations...

相似试验